Arrhythmia and Death Following Percutaneous Revascularization in Ischemic Left Ventricular Dysfunction: Prespecified Analyses From the REVIVED-BCIS2 Trial
Divaka Perera, Simon Redwood(St Thomas' Hospital), John P. Greenwood(University of Leeds), Mark C. Petrie(British Heart Foundation), Marie Wood(University of Colorado Cancer Center), Ceri H. Davies, Richard D. Evans(London School of Hygiene & Tropical Medicine), Elliot J. Smith(Barts Health NHS Trust), Christopher A. Rinaldi(St Thomas' Hospital), Holly Morgan(King's College London), George Amin‐Youssef(King's College Hospital NHS Foundation Trust), Margaret McEntegart(Golden Jubilee National Hospital), Julian Strange(NIHR Bristol Cardiovascular Biomedical Research Unit), Amedeo Chiribiri(King's College London), Stuart Watkins(Golden Jubilee National Hospital), Eltigani Abdelaal(Wythenshawe Hospital), Bhavik Modi, Louise Cowan, Tim Clayton(London School of Hygiene & Tropical Medicine), Lucy Clack, Haseeb Rahman(Guy's and St Thomas' NHS Foundation Trust), Karen M. Wilson(Child Health and Development Institute), Natalia Briceno, Marion McAdam, Amy Raynsford, Peter O’Kane(Royal Bournemouth Hospital), Brian Clapp(St. Thomas Hospital), Fozia Ahmed(Keele University), M. J. Ryan(King's College London), Elizabeth McPherson(Marshfield Clinic), Simon Walsh(University of Sheffield), Roshan Weerackody(Barts Health NHS Trust), Matthew Dodd(London School of Hygiene & Tropical Medicine), Aadil Shaukat(Golden Jubilee National Hospital), Kai Hogrefe(Kettering General Hospital), Antonis N. Pavlidis(St Thomas' Hospital), Nicholas Jenkins(Sunderland Royal Hospital), Michelle A. Anderson, Gerry Carr‐White, Sophie Arnold, Timothy Lockie(University of Colorado Denver), Miles Behan(Edinburgh Royal Infirmary), Adam K McDiarmid(University of Leeds), Paul Rocchiccioli(Golden Jubilee National Hospital)
Cited by 36
Related Papers
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
|New England Journal of Medicine|2019|6.8k
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials
|The Lancet Diabetes & Endocrinology|2019|1.6k
Current State of Knowledge on Aetiology, Diagnosis, Management, and Therapy of Peripartum Cardiomyopathy: A Position Statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy
|European Journal of Heart Failure|2010|1.1k
18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial
|The Lancet|2013|942
Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina
|Journal of the American College of Cardiology|2018|772